Pharma-Bio Serv (PBSV) Other Non-Current Liabilities (2018 - 2024)

Pharma-Bio Serv's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $660903.0 for Q4 2024.

• Other Non-Current Liabilities for Q4 2024 came in at $660903.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2024 was $660903.0 (changed N/A YoY), and the FY2024 annual result was $660903.0, changed N/A from the prior year.
• Other Non-Current Liabilities came in at $660903.0 for Q4 2024 at Pharma-Bio Serv, down from $1.4 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.6 million in Q4 2022 to a low of $17950.0 in Q1 2020.
• A 5-year average of $385000.7 and a median of $17950.0 in 2020 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities sank 75.54% in 2021 and soared 9031.19% in 2022, its largest moves.
• Over 5 years, Other Non-Current Liabilities stood at $73389.0 in 2020, then sank by 75.54% to $17950.0 in 2021, then soared by 9031.19% to $1.6 million in 2022, then decreased by 12.9% to $1.4 million in 2023, then tumbled by 53.7% to $660903.0 in 2024.
• The last three Other Non-Current Liabilities figures came in at $660903.0 (Q4 2024), $1.4 million (Q3 2023), and $1.4 million (Q2 2023), per Business Quant data.